Dyne Therapeutics, Inc. short interest in 2025
In 2025, Dyne Therapeutics, Inc.'s disclosed short interest ran from 9.24% of shares outstanding on 15 Jan 2025 to 12.11% on 31 Dec 2025, a change of +2.87 percentage points. The year's high was 22.46% on 30 May 2025 and its low 9.24% on 15 Jan 2025, averaging 12.87% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 18.00 days on 30 May 2025. Full history: Dyne Therapeutics, Inc..
Cite this page
By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2025 in figures
- Start of year
- 9.24% (15 Jan 2025)
- End of year
- 12.11% (31 Dec 2025)
- Change
- +2.87 pp
- High
- 22.46% (30 May 2025)
- Low
- 9.24% (15 Jan 2025)
- Average
- 12.87%
- Highest days to cover
- 18.00 (30 May 2025)
- SEC filings marked
- 9
Every report in 2025
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2025 | 9.24% | 3.68 | results (8-K) |
| 31 Jan 2025 | 9.39% | 2.99 | |
| 14 Feb 2025 | 10.71% | 7.06 | |
| 28 Feb 2025 | 11.46% | 7.68 | 10-K filed, results (8-K) |
| 14 Mar 2025 | 12.17% | 7.38 | |
| 31 Mar 2025 | 11.14% | 5.64 | |
| 15 Apr 2025 | 15.00% | 4.92 | |
| 30 Apr 2025 | 13.07% | 5.74 | |
| 15 May 2025 | 20.41% | 6.78 | 10-Q filed, results (8-K) |
| 30 May 2025 | 22.46% | 18.00 | |
| 13 Jun 2025 | 18.14% | 9.08 | |
| 30 Jun 2025 | 14.40% | 4.86 | |
| 15 Jul 2025 | 13.84% | 3.79 | |
| 31 Jul 2025 | 11.46% | 6.64 | 10-Q filed, results (8-K) |
| 15 Aug 2025 | 12.05% | 4.84 | |
| 29 Aug 2025 | 11.28% | 6.44 | |
| 15 Sep 2025 | 10.76% | 7.64 | |
| 30 Sep 2025 | 12.49% | 6.33 | |
| 15 Oct 2025 | 12.02% | 7.40 | |
| 31 Oct 2025 | 10.59% | 4.74 | |
| 14 Nov 2025 | 11.98% | 6.52 | 10-Q filed, results (8-K) |
| 28 Nov 2025 | 12.22% | 7.12 | |
| 15 Dec 2025 | 10.47% | 3.55 | |
| 31 Dec 2025 | 12.11% | 9.02 |
See also: Dyne Therapeutics, Inc.'s full history · most shorted US stocks of 2025 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.